Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
0 Visninger
• 07/04/23
0
0
Indlejre
administrator
Abonnenter
Earn CME for related activities: https://www.naccme.com/oln
This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.
© 2018 NACCME, an HMP Company
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer